Bhubaneswar, May 16: Polycystic Ovary Syndrome (PCOS), long recognised as one of the most common health concerns among women, has a new name. Experts worldwide now refer to it as PMOS — Polyendocrine Metabolic Ovarian Syndrome.

This change comes after more than a decade of global research, led by Monash University and published in The Lancet. The renaming reflects a key insight: the condition extends beyond the ovaries, affecting hormones, metabolism, and multiple body systems, rather than being solely a reproductive issue.

Speaking about the update, renowned Odisha gynaecologist Dr. Sujata Kar explained that the term PCOS was misleading. “The so-called ‘cysts’ in the ovaries are usually normal immature follicles, not pathological cysts. The condition is a complex endocrine and metabolic disorder, not just an ovarian problem,” she said.

Dr. Kar added that the term PMOS better captures the broader impact on women’s health, including hormonal imbalances, insulin resistance, weight gain, and ovulatory issues. Diagnosis now relies more on symptoms like irregular periods, acne, weight fluctuations, and fertility challenges, rather than solely on ultrasound findings. A normal scan does not rule out PMOS.

Regarding fertility, Dr. Kar noted that PMOS can cause irregular ovulation, potentially reducing chances of natural conception. However, with timely medical care, lifestyle modifications, and proper guidance, many women manage the condition effectively and achieve pregnancy.

Experts emphasise that PMOS is not a new disease, but a more accurate and comprehensive way to understand a condition that has affected millions of women for decades.